China Series – How to Enter the Pharmaceuticals Industry in China

  • 10:00, 4 Mar 21 - 12:00, 4 Mar 21
  • 25 Science Park, Cambridge
  • Print page
In this second workshop of our China Series on the Life Sciences, we turn our attention to the country’s pharmaceuticals market. As in the first, we're doubling down and concentrating on bringing Chinese companies who are interested in working with UK partners, narrowing your search for a viable partner in your Chinese expansion.

As far as possible, these talks will be conducted with an English-speaking partner from China, with mediation and translation provided by TusPark UK if necessary.

Full programme schedule to be found shortly at sign-up page, but confirmed speakers to include:

AstraZeneca - A British pharmaceutical company who has successfully crossed into China, and now looking for other UK partners

Pharmacin - A Chinese pharmaceutical company based in Shenzhen

WuXi AppTec - One of China's largest CROs (Contract Research Organization) already working with Chinese pharmaceutical companies, and also interested in working with UK partners

CMS Ventures - A corporate venture arm of China Medical System, investing in early-stage companies in the UK, and based in Cambridge

Plus: Find out more about TusPark UK's China-UK Innovation Centre in Beijing, that gives you an immediate presence in China, even while you are operating in the UK

The objective of these talks is for TusPark UK to facilitate health and life science companies with accessing the Chinese market: through education, knowledge sharing, and eventually, partner finding. Talks are followed up with advice and consultation with the TusPark UK team, to signpost you on further actions based on what you need.